Ginkgo’s $17.5 Bln SPAC Deal Presupposes Success

Ginkgo Bioworks is promising a future that’s grown rather than built. That is the story underlying the company’s $17.5 billion valuation in a deal with special purpose acquisition company Soaring Eagle Acquisition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.